Benefits were consistent across all key subgroups, including patients previously treated with covalent BTK inhibitors
A brand from Opella will be part of the official NASA astronaut formulary
Highlights Mirvetuximab-based regimen promise
Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model
The license is valid for five years, effective from April 9, 2026
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
Each program will rely on partnerships between Novartis teams and local networks—including health authorities, community organizations and private sector groups
Subscribe To Our Newsletter & Stay Updated
